1. Trang chủ
  2. » Giáo Dục - Đào Tạo

Bệnh mạch vành ổn định với tổn thương nhiều nhánh ở người có bệnh thận mạn Khi nào nên can thiệp

34 437 0

Đang tải... (xem toàn văn)

Tài liệu hạn chế xem trước, để xem đầy đủ mời bạn chọn Tải xuống

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Định dạng
Số trang 34
Dung lượng 4,34 MB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

Circulation 2003 Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany... Circulation 2003 Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany..

Trang 1

Stable CKD: when do we need PCI?

Germany

Trang 2

Conflicts of Interest

Nothing to declare

Trang 3

Stages of CKD

Sarnak et al Circulation 2003

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 4

CKD and Mortality

C.,) contil i a

i H eart and Vascular Center

Cardiovascularmortalityin the general population(NCHS) and

-o-Dialysis Fermle-tr- Dialysis Black -&- Dialysis White *- Transplant

Trang 5

CKD and Cardiovascular Disease

Sarnak et al Circulation 2003

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 6

CKD and MACE

N=16.958

Di Angelantonio et al BMJ 2010

Trang 7

How should I treat?

67 year old patient on hemodialysis

Symptoms: progressive over 3 months (CCS II, NYHA III) Echo: hypokinesia of inferior wall, EF 45%

Laboratory: mildly elevated Troponin T (0.2 µg/l)

ECG: SR 70 and RBB

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 8

How should I treat?

67 year old patient on hemodialysis

Symptoms: progressive over 3 months (CCS II, NYHA III) Echo: hypokinesia of inferior wall, EF 45%

Laboratory: mildly elevated Troponin T (0.2 µg/l)

ECG: SR 70 and RBB

Stable or instable patient?

Trang 9

Serum phosphorus and cardiac injury &) r contilia ) Heart and Vascular Center

6000.20

sC>

100

80250

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

• 0

Trang 10

Phosphate and CMC Apoptosis

Wang et al Med Sci Mon 2014

Trang 11

Troponin and prognosis in CKD

Metaanalysis of 124 trials adjustng for age and CAD

Michos et al AHRQ Publication No 14-EHC030-EF 2014

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 12

How should I treat?

67 year old patient on hemodialysis

Symptoms: progressive over 3 months (CCS II, NYHA III) Echo: hypokinesia of inferior wall, EF 45%

Laboratory: mildly elevated Troponin T (0.2 µg/l)

remaining stable after 3 and 12 hours

ECG: SR 70 and RBB

Trang 13

How should I treat?

67 year old patient on hemodialysis

Symptoms: progressive over 3 months (CCS II, NYHA III) Echo: hypokinesia of inferior wall, EF 45%

Laboratory: mildly elevated Troponin T (0.2 µg/l)

remaining stable after 3 and 12 hours

ECG: SR 70 and RBB

Coronary angiography indicated?

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 14

CKD and Coronary Angiography

Trang 15

Platelet activation in CKD

306 patents with diabetes mellitus on DAPT

Angiolillo et al JACC 2010

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 16

GFR and outcome after PCI

13.307 patents from 5 TIMI trials with NSTEMI-ACS

Gibson et al EHJ 2004

Trang 17

NSTEMI ACS & early angio in CKD

Charytan et al Clin J Am Soc Nephrol 2009

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 18

How should I treat?

67 year old patient on hemodialysis

Symptoms: progressive over 3 months (CCS II, NYHA III) Echo: hypokinesia of inferior wall, EF 45%

Laboratory: mildly elevated Troponin T (0.2 µg/l)

remaining stable after 3 and 12 hours

ECG: SR 70 and RBB

Trang 19

Need for revascularizaton?

Symptomatic indication:

is the patient already on optimal medical therapy?

COURAGE: Boden et al NEJM 2007

Trang 20

Need for revascularizaton?

Prognostic indication:

ischemic burden > 10%?

COURAGE NUCLEAR SUBSTUDY:

Shaw et al Circulation 2008

Trang 21

CKD in randomized trials* on CAD

Trials where CKD is exclusion criterion Trials reporting CKD as baseline condition

*(86 trials randomizing 411 653 patients)

Charytan et al Kidney Int 2006

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 22

CABG vs PCI in HD patients

C.,) contil i a

i H eart and V asc ul a r Center

Table 6 Comparison of CABG and PCI in HD Patients

" Art e rial R ev asc ulariza ti n Th e api es Stud y s u s tud y; te nd poi n t w as co mb in e d ci d e n ce of d e t h , my oc ardial infar c ti , s tr ok e

t/J = s t e n t s ; PCI = p e ut an e o s co ro n ary int erv e nti o Oth e r a b br e v iati o s as in T ab le 5

Gupta et al JACC 2004

Trang 23

PCI vs CABG in CKD: all events

C.,) contil i a

i H eart and V asc ul a Center

Table 6 : Comparison of cumul ative events between ESRD pat i ents who underwent CABGor PC I

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 24

PCI vs CABG in CKD: repeat revascularization

Zheng et al EJCTS 2012

Trang 25

PCI vs CABG in CKD: myocardial infarction

Zheng et al EJCTS 2012

Trang 26

PCI vs CABG in CKD: late mortality C

i .,)contiliaH eart and V asc ul a r Center

3 97 16 3 9 9 92 4201 14 93 2 16 5

60 23 2

74 1

47 130 29 6 244 6668 55 153 28 54 29

1

2 6 324

1

35 28 2 7 75 64

1

76 3 13 24

24 20 19 688 7 92 122 46

4

163 9116 7 147 18 33 75

Trang 27

PCI vs CABG in CKD: early mortality C.,) i contilH eart and i aV asc ul a r Center

0

7 9 5 3 57 3 3 23 0 3

60 23 22 7 9 47 130 29 65 6668 55 130 28 5 29

1 0 1 371

2

20

1

6887 92 122 46 40 9116

7

322

1

33 75

0.80 (0 08 - 8.42)

0.86 (0 06 - 12 89) 2.33 (2 07 - 2 61)

13 70 ( 1 74 - 108 11 )

4 22 (0 93-19 16) 0.99 (0.36 - 2 74 )

8 0 486 3 22 0

..

1 4 1.4

.

•' -

I I

Trang 28

MV-PCI vs CABG in CKD

21,981 CKD patients (US Renal Data System 1997-2009) undergoing MV-revascularization

Chang et al JASON 2012

Trang 29

CKD in the FREEDOM trial

Baber et al EHJ 2016

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

C AB G P erformed (n = 668)

PCI Perfo r med

( n = 7 24)

P C I Pe rf or m e ( n = 225)

I

L

W ithou t CKD ( n = 1 9)

n = 27 )

F R EE DOM Su bjects (n = 1 00 )

l ( Missing S erum C reatinin e )

_

_

Trang 30

CKD in the FREEDOM trial

Baber et al EHJ 2016

Trang 31

Discussion in Heart Team

67 year old patient on hemodialysis

Symptoms: progressive over 3 months (CCS II, NYHA III)

Echo: hypokinesia of inferior wall, EF 45%

Laboratory: mildly elevated Troponin T (0.2 µg/l)

remaining stable after 3 and 12 hours

ECG: SR 70 and RBB

Patient refused by surgeons (porcelain aorta)

Contilia Heart- and Vascular Center, Elisabeth Krankenhaus Essen, Germany

Trang 32

How did I treat

RCA: 2xDES 3.0/18 mm

LAD: DES 3.5/18 mm LCX: DES 3.0/18 mm

Trang 33

1 Chronic kidney disease patients are at a high risk for

having ischemic heart disease and its complications.

2 Troponin dynamics rather than a single Tropnin

measurement may be useful to diagnose ACS in

patients.

these

3 Indications for revascularization are assumed to

the the same as in other patients.

be

4 Despite randomized trials are lacking, available data

indicate that CABG may be preferrable in therse

patients

Contilia Herz- und Gefäßzentrum, Elisabeth Krankenhaus Essen

Trang 34

f

Ngày đăng: 03/12/2016, 23:46

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

🧩 Sản phẩm bạn có thể quan tâm